Home Here's why trial data coming this month from Vertex is a big deal
 

Keywords :   


Here's why trial data coming this month from Vertex is a big deal

2015-03-14 13:11:36| Biotech - Topix.net

Vertex Pharmaceuticals hasn't even received FDA approval for its second drug to treat cystic fibrosis, but investors are already weighing the impact of trial data expected this month from what could become its third. That's because the Phase 2B trial data for the drug known as VX-661, which Vertex has said it will present by the end of March, represents only the second time the Boston biotech has given any human trial data on the effectiveness of the drug.

Tags: data big month coming

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »